


To achieve long-term capital and income growth through investing principally in UK equities.
| Name | % Net Assets |
|---|---|
| Royal Dutch Shell | 7.4% |
| BP | 6.5% |
| VODAFONE GROUP | 6.2% |
| GlaxoSmithKline | 6.1% |
| BRITISH AMERICAN TOBACCO | 4.2% |
| ASTRAZENECA PLC | 4.0% |
| HSBC HLDGS | 3.9% |
| Sage Group | 2.7% |
| CENTRICA PLC | 2.4% |
| BG GROUP | 2.3% |
| Key | % Net Assets |
|---|---|
| 7.4% | |
| 6.5% | |
| 6.2% | |
| 6.1% | |
| 73.8% |
| Date | 23-Nov-2023 |
|---|---|
| NAV | 88.50p |
| Currency | GBP |
| Change | -0.23p |
| % | -0.26% |
| YTD change | 88.50p |
| YTD % | n/a |
| Fund Inception | 17/11/1997 |
|---|---|
| Fund Manager | n/a |
| TER | 1.77 (31-Oct-2013) |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | n/a |
| Savings | £100 |
| Charges | |
|---|---|
| Initial | 5.25% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.12 |
You are here: research